Effective October 2, 2018, it became mandatory for all health care practitioners to consult and review California’s Controlled Substance Utilization Review and Evaluation System (CURES) 2.0 system prior to prescribing, ordering, administering, or furnishing a Schedule II-IV controlled substance. It is imperative that physicians familiarize themselves with the requirements of this mandate in order to avoid liability risks and administrative sanctions. 

Featuring a keynote series from the highly acclaimed, Ritz-Carlton Leadership Center, the conference will provide valuable insights into improving the patient experience in your medical practice.

Notwithstanding the usual suspects that hinder electronic medical record implementation — initial costs, interoperability problems, training burdens, and altered physician-patient dynamics — there’s also the risk of a pure system malfunction. In a malpractice suit after an admitted malfunction, a physician’s actions will still be scrutinized.

You may have already read about CAPAdvantage, our suite of no-cost and discounted practice management programs. Leveraging the buying power of your 12,000 member-strong cooperative, all programs are administered by highly reputable, CAP-vetted vendors. But can these programs really save your practice time, money, and aggravation?

According to a new report on sexual harassment released by the Equal Employment Opportunity Commission, data for fiscal year 2018 shows a more than 50 percent increase in sexual harassment lawsuits filed by the agency, and a more than 12 percent increase in the number of charges it received over fiscal year 2017.